Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533425 · ClinicalTrials.gov registry record
Practical Approaches to Care in Emergency Syncope
A clinical trial of Syncope and Presyncope, sponsored by Columbia University.
- Completed
- Registry status
- 1,297
- Enrollment target
- 5
- Study locations
NCT04533425: Completed study of Syncope and Presyncope, sponsored by Columbia University.
NCT04533425 is a study of Syncope and Presyncope that has completed, run by Columbia University. The registered enrollment target is 1,297 participants, above the 733-participant average among 11 other Syncope trials with a reported enrollment target (77% higher). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04533425, a study of Syncope and Presyncope, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 1,297 participants
- Enrollment target
- 5
- Study locations
Study Summary
Syncope, or transient loss of consciousness, is a common reason for visit to the Emergency Department and often leads to extensive testing and hospitalization. Using objective risk scores to determine which patients with syncope will actually benefit from these interventions, and which can be safely discharged home with minimal testing, is critical to providing sensible medical care. This study will evaluate the validity of two syncope risk-stratification tools and investigate their impact on healthcare utilization and patient safety, thus improving the quality of care for the 1-2 million patients who experience syncope every year in the United States
Primary Outcome
A combination of clinical, electrocardiographic, and laboratory variables to predict the risk of serious clinical outcomes at 30 days. Full scale range from 0-6, higher score indicates higher risk of a serious cardiac event or death.
Conditions Studied
Study Locations (5)
New York
- Icahn School of Medicine at Mount Sinai - New York
- Columbia University Irving Medical Center - New York
- University of Rochester - Rochester
California
- UC Davis - Sacramento
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,297 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2024-09-30 |
What the finished NCT04533425 record still lists
NCT04533425 is an observational study that tracks outcomes without assigning an intervention. Its 1,297 participants enrollment target places it among the larger protocols in the corpus, above the 733-participant average among 11 other Syncope trials with a reported enrollment target (77% higher).
The record links to 2 conditions, with Syncope appearing as the primary indexed condition, and to 0 interventions.
NCT04533425 lists 5 locations in 3 states (New York, California, Tennessee).
Frequently Asked Questions
What is clinical trial NCT04533425 about?
NCT04533425 is a clinical study titled "Practical Approaches to Care in Emergency Syncope". Syncope, or transient loss of consciousness, is a common reason for visit to the Emergency Department and often leads to extensive testing and hospitalization. Using objective risk scores to determine which patients with syncope will actually benefit from these interventions, and which can be safely...
What is the current status of trial NCT04533425?
This trial is currently completed. The enrollment target is 1,297 participants. The study started on 2020-09-14. Estimated completion is 2024-09-30.
What conditions does trial NCT04533425 study?
This clinical trial studies the following conditions: Syncope, Presyncope.
Who is sponsoring clinical trial NCT04533425?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04533425 being conducted?
This trial has 5 study locations across California, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syncope
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04533425's enrollment target sits among peer trials
1,297 3rd of 11 higher than 9 of 11 other Syncope trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Syncope trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
-
Genetic Markers of Cardiovascular Disease in Epilepsy
RECRUITING
-
BAsel Syncope EvaLuation (BASEL IX) Study
ACTIVE NOT RECRUITING
-
Pediatric Adhesion and New Dermal Approach Study
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI